MedPath

Effect of Barbed Suture Fascia Closure on Incisional hernia in Midline Laparotomy for Gynecological Diseases (BARBHER)

Not Applicable
Completed
Conditions
Diseases of the genitourinary system
Registration Number
KCT0005156
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
174
Inclusion Criteria

1. Female patients planning to undergo elective midline laparotomy for gynecological diseases.
2. Over 18 years old.
3. ECOG performance status 0 - 2

Exclusion Criteria

1. Patients with previous or present abdominal incisional hernia.
2. Pregnant patients.
3. Patients receiving external radiation treatment to the pelvis or abdomen.
4. Patients allergic to PDS components.
5. Patient with diseases that affect wound healing including uncontrolled diabetes, autoimmune vasculitis, and hepatocirrhosis.
6. BMI>35
7. Patients are excluded if they have used or are expected to use drugs that may affect wound healing such as bevacizumab. In case where bevacizumab is used, participation is possible if they have a four-week washout period before and after surgery, respectively.
8. Patients who have had an abdominal midline laparotomy for the last 6 months.
9. If patients had surgery for suspected infection.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1-year cumulative incidence of incisional hernia
Secondary Outcome Measures
NameTimeMethod
safety (Comparison of prevalence and grade of adverse events between SS-PDS experimental group and control group.)
© Copyright 2025. All Rights Reserved by MedPath